BPC-157
Compounded BPC-157 sourced through a licensed US pharmacy and placed inside clinician review, not a research-vendor checkout.
A high-scrutiny compounded IGF-1 LR3 prescription for athletes treating recovery capacity as a serious clinical question.
From $179/month
Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.
Every serious training week has a hidden number: how many genuinely hard sessions you can absorb before the next one starts borrowing from the one after it. Most people try to raise that number by pushing harder. That works until recovery, not motivation, becomes the thing setting the ceiling.
IGF-1 LR3 belongs in that between-session conversation.
Growth hormone tells the liver to produce IGF-1, and IGF-1 is the signal that reaches muscle and connective tissue and tells them to grow. Most circulating IGF-1 is bound to carrier proteins. LR3 is modified around that constraint.
Research found LR3 substantially more potent than ordinary IGF-1 in cells that produce binding proteins, but less potent in cells that do not.1 The advantage points to reduced binding-protein capture rather than a stronger grip on the receptor. Research also found that LR3 clears from blood considerably faster than ordinary IGF-1, not slower.2
That is what makes the molecule worth considering. It is not a promise that three hard training days become five, but a different biological target for the part of performance that happens after the session ends.
Dose, duration, and follow-up stay inside a clinician-led plan built around your training context and medical history.
You know the exact point in the week when high-quality work starts turning into accumulated fatigue. Your willingness to train has not changed. The number of sessions you can truly absorb has.
The workout that once cost a day now costs two. You are not asking for more motivation. You are asking why the recovery bill keeps getting larger.
The plan calls for six weeks. Your body starts negotiating at three. You want to look at the biology between training blocks instead of finding another way to push through it.
Compounded IGF-1 LR3 is not an FDA-approved drug product. Whether it is appropriate for you is determined by a licensed provider from your full Assessment.
Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.
Compounded by a licensed 503A pharmacy. Prescribed by a licensed provider after clinical review.
3-month commitment
Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.
*Price reflects a 3 month commitment. Other billing options are shown at checkout.
This one carries real risk and the screening is not a formality. That is why your provider sets timing around food, and why any diabetes diagnosis or glucose-lowering medication has to be on your intake. Duration is planned rather than open-ended. Human safety data for this analogue is limited, which is the reason this sits with a clinician rather than in a shopping cart.
If your provider determines you are not a candidate for any available treatment, any consultation fee paid will be refunded within 7–10 business days. You are not left guessing. Your clinician explains the reasoning and, where it helps, what a better path might look like. Reviews are typically completed in under 24 hours.
Human trials have not established muscle growth from IGF-1 LR3 in healthy adults. IGF-1 is a growth signal, LR3 interacts differently with binding proteins, and the potency difference in the cited cell systems tracks with that biology.1 Your clinician evaluates what the treatment does in your case from your actual response.
IGF-1 is an approved medicine in the United States, prescribed as Increlex for people whose bodies do not produce enough of it on their own. IGF-1 LR3 is a modified form of that same signal, built to stay free in the blood rather than bound up by carrier proteins. No compounded medication is FDA-approved, including this one. Compounded medicines are made to your individual prescription by a licensed pharmacy rather than manufactured and approved as a finished drug product.
There is no honest universal timeline for a performance-recovery question like this. Your provider sets expectations from your training load, history, baseline, and what actually happens after treatment begins.
A molecule this close to fundamental growth signaling should make the care around it more important, not less. Here, a licensed provider decides whether IGF-1 LR3 belongs in your plan and a licensed US pharmacy compounds it to an individual prescription. The FDA has found products sold as research chemicals under false labels, some naming compounding pharmacies that do not exist, and warns they “can pose risks of serious harm” by bypassing the body’s defenses.F4 Testing has found wide variation in purity and in how much of the compound is actually in the vial. AnthologyRX gives you medical accountability around the molecule, not permission to self-direct a growth signal because the marketing sounded convincing.
Any time, before your renewal date. No phone calls required.
Compounded BPC-157 sourced through a licensed US pharmacy and placed inside clinician review, not a research-vendor checkout.
Compounded oral BPC-157 delivered directly into the digestive tract, with a clinician deciding whether capsule or injection fits the case.
A compounded BPC-157 and TB-500 prescription pairing BPC-157's tissue-repair signaling with thymosin beta-4 biology in cell movement and wound closure.